Drug Enforcement Administration November 2008 – Federal Register Recent Federal Regulation Documents

Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: E8-27641
Type: Notice
Date: 2008-11-20
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: E8-27640
Type: Notice
Date: 2008-11-20
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: E8-27638
Type: Notice
Date: 2008-11-20
Agency: Drug Enforcement Administration, Department of Justice
Controlled Substances: Final Revised Aggregate Production Quotas for 2008
Document Number: E8-26798
Type: Notice
Date: 2008-11-12
Agency: Drug Enforcement Administration, Department of Justice
This notice establishes final 2008 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act (CSA). The DEA has taken into consideration comments received in response to a notice of the proposed revised aggregate production quotas for 2008 published July 1, 2008 (73 FR 37496).
Exempt Chemical Mixtures Containing Gamma-Butyrolactone
Document Number: E8-26606
Type: Proposed Rule
Date: 2008-11-12
Agency: Drug Enforcement Administration, Department of Justice
DEA is proposing that chemical mixtures that are 70 percent or less gamma-butyrolactone (GBL), by weight or volume, be automatically exempt from regulatory controls under the Controlled Substances Act (CSA). DEA is seeking through this rulemaking to exempt only those chemical mixtures that do not represent a significant risk of diversion. If finalized as proposed, this regulation would result in GBL chemical mixtures, in concentrations greater than 70 percent, becoming subject to List I chemical regulatory requirements of the CSA, except if exempted through an existing categorical exemption. DEA is taking this action because there is a serious threat to the public safety associated with the ease by which GBL is chemically converted to the schedule I controlled substance gamma-hydroxybutyric acid (GHB). DEA recognizes that concentration criteria alone cannot identify all mixtures that warrant exemption. As a result, 21 CFR 1310.13 provides for an application process by which manufacturers may obtain exemptions from CSA regulatory controls for those GBL chemical mixtures that are not automatically exempt under the concentration criteria.
Controlled Substances: Proposed Aggregate Production Quotas for 2009
Document Number: E8-26609
Type: Notice
Date: 2008-11-07
Agency: Drug Enforcement Administration, Department of Justice
This notice proposes initial year 2009 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act (CSA).
Drug Enforcement Administration
Document Number: E8-26598
Type: Notice
Date: 2008-11-07
Agency: Department of Justice, Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Document Number: E8-26145
Type: Notice
Date: 2008-11-03
Agency: Drug Enforcement Administration, Department of Justice
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.